We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHX
8626
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
$37K ﹤0.01%
884
+72
+9% +$2.95K
AT
8627
PUT
DELISTED
Atlantic Power Corporation
AT
$37K ﹤0.01%
15,400
-27,500
-64% -$65.5K
BLPH
8628
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$37K ﹤0.01%
4,143
+522
+14% +$5K
ANFI
8629
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$37K ﹤0.01%
48,732
+28,793
+144% +$34.3K
CLDX icon
8630
CALL
Celldex Therapeutics
CLDX
$3.28B
$36K ﹤0.01%
13,300
-5,800
-30% -$19.7K
COCP icon
8631
Cocrystal Pharma
COCP
$15.6M
$36K ﹤0.01%
1,264
+30
+2% +$891
GROW icon
8632
US Global Investors
GROW
$38.9M
$36K ﹤0.01%
19,664
-15,168
-44% -$18.3K
REI icon
8633
CALL
Ring Energy
REI
$360M
$36K ﹤0.01%
+11,200
New +$49.8K
SIFY
8634
Sify Technologies
SIFY
$1.13B
$36K ﹤0.01%
4,290
+2,204
+106% +$19K
XPL icon
8635
Solitario Resources
XPL
$75.2M
$36K ﹤0.01%
+112,942
New +$41K
BBIG
8636
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$36K ﹤0.01%
+1,148
New +$58.3K
NVCN
8637
DELISTED
Neovasc Inc.
NVCN
$36K ﹤0.01%
+295
New +$36.7K
DOMH icon
8638
Dominari Holdings
DOMH
$64.2M
$35K ﹤0.01%
+816
New +$45K
PANL icon
8639
Pangaea Logistics
PANL
$489M
$35K ﹤0.01%
+10,325
New +$35.2K
STCN
8640
DELISTED
Steel Connect, Inc. Common Stock
STCN
$35K ﹤0.01%
2,079
-2,503
-55% -$44.3K
ATRS
8641
CALL
DELISTED
Antares Pharma, Inc.
ATRS
$35K ﹤0.01%
10,700
-11,600
-52% -$33.6K
FOMX
8642
CALL
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$35K ﹤0.01%
14,500
-51,500
-78% -$154K
SNNA
8643
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$35K ﹤0.01%
40,555
+24,480
+152% +$38.3K
BTE icon
8644
PUT
Baytex Energy
BTE
$3.06B
$34K ﹤0.01%
22,000
-18,700
-46% -$33.9K
PLX icon
8645
Protalix BioTherapeutics
PLX
$180M
$34K ﹤0.01%
7,143
+4,516
+172% +$19.1K
VATE icon
8646
PUT
INNOVATE Corp
VATE
$106M
$34K ﹤0.01%
1,450
-130
-8% -$3.2K
LUMO
8647
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$34K ﹤0.01%
+2,522
New +$38.1K
MGI
8648
PUT
DELISTED
MoneyGram International, Inc. New
MGI
$34K ﹤0.01%
+13,600
New +$30.5K
BOXL icon
8649
Boxlight
BOXL
$5.13M
$33K ﹤0.01%
+7
New +$34.3K
DSX icon
8650
CALL
Diana Shipping
DSX
$311M
$33K ﹤0.01%
14,303
-8,868
-38% -$19.5K

Similar funds

Citadel Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
  • Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.